Cart
sales@molnova.com
Ganolactone A
CAS No. 173268-82-1
Ganolactone A( ——— )
Catalog No. M38464 CAS No. 173268-82-1
Ganolactone is a triterpenoid compound. Ganolactone has a weak inhibitory effect on EBV early antigen.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameGanolactone A
-
NoteResearch use only, not for human use.
-
Brief DescriptionGanolactone is a triterpenoid compound. Ganolactone has a weak inhibitory effect on EBV early antigen.
-
DescriptionGanolactone is a triterpenoid compound. Ganolactone has a weak inhibitory effect on EBV early antigen.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number173268-82-1
-
Formula Weight456.57
-
Molecular FormulaC27H36O6
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Weng CJ, et al. The in vitro and in vivo experimental evidences disclose the chemopreventive effects of Ganoderma lucidum on cancer invasion and metastasis. Clin Exp Metastasis. 2010 May;27(5):361-9.?2. Akihisa T, et al. Anti-inflammatory and anti-tumor-promoting effects of triterpene acids and sterols from the fungus Ganoderma lucidum. Chem Biodivers. 2007 Feb;4(2):224-31.?
molnova catalog
related products
-
Cys(NPys)-Antennaped...
Cys(Npys) Antennapedia Peptide, amide is a peptide. Cys(Npys) Antennapedia Peptide, amide can be used for various biochemical studies.
-
2'-Hydroxyacetopheno...
2’-Hydroxyacetophenone is a phenolic compound used in the synthesis of potential anti-myobacterial and anticancer agents.
-
PACAP (6-38), human,...
PACAP (6-38), human, ovine, rat is a potent antagonist of PACAP 38. PACAP (6-38) is much more potent and selective than PACAP (6-27) in the inhibition of PACAP-27-stimulated pituitary adenylate cyclase.
